Additionally, reduction of lung tissue pathology was confirmed in the MET-treated mice, and the number of lung CD8+ IFN-γ+ cells was increased in MET-treated mice in both unstimulated and Mtb-stimulated groups, suggesting an enhanced immune response to TB (132). The gene discussed is IFNG; the disease is tuberculosis.